Scopus BioPharma Inc. (SCPS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -0.18 | -1.02 | -17.14 | -32.96 | -129.24 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -0.31 | 7.04 | -108.29 | -1.07K | -16.65K | n/a |
P/FCF Ratio | -0.25 | -2.48 | -78.53 | -41.73 | -118.63 | n/a |
P/OCF Ratio | -0.25 | -2.48 | -78.53 | -41.81 | -118.63 | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | -1.25 | n/a | n/a | n/a |
Quick Ratio | 0.05 | 1.96 | 0.52 | 0.04 | 0.96 | 1.91 |
Current Ratio | 0.05 | 1.96 | 0.52 | 0.90 | 0.96 | 1.91 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -35.67 | -14.38 | n/a | n/a | n/a |
Return on Equity (ROE) | 1.77 | -6.9 | 6.32 | 32.46 | 128.80 | n/a |
Return on Assets (ROA) | -29.6 | -3.39 | -5.86 | -3.49 | -5.17 | n/a |
Return on Capital (ROIC) | 1.66 | -6.88 | 5.55 | 32.46 | 128.80 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |